Literature DB >> 23123415

Large liposarcoma developing in the ischiorectal fossa: Report of a rare case.

Ryo Seishima1, Yoshiyuki Ishii, Hirotoshi Hasegawa, Takashi Endo, Hiroki Ochiai, Koji Okabayashi, Makio Mukai, Yuko Kitagawa.   

Abstract

INTRODUCTION: We herein report an extremely rare case of a liposarcoma developing in the ischiorectal fossa that was completely resected using a transsacral approach. PRESENTATION OF CASE: A 74-year-old man was admitted to our institute because of a large perianal tumor. A pelvic magnetic resonance imaging (MRI) revealed an 8cm×7cm×5cm sized encapsulated heterogeneous tumor on the right side of the ischiorectal fossa. Transsacral excision was performed under a diagnosis of liposarcoma. The tumor was partially fixed to the external sphincter and puborectalis. Therefore, the muscles were partially resected to ensure sufficient margins. Histopathological examination revealed a well differentiated liposarcoma and negative surgical margins. DISCUSSION: The basic treatment strategy of liposarcoma is surgical resection, whereas the effects of chemotherapy or radiotherapy remain limited. Although no postoperative adjuvant therapy has been performed in our case, no recurrences have occurred for 1 year after surgery.
CONCLUSION: Although the curative resection of large tumors located in the ischiorectal fossa is usually difficult, the complete resection of liposarcoma is the main potentially curative treatment. A transsacral approach is useful for a complete resection.
Copyright © 2012 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.

Entities:  

Year:  2012        PMID: 23123415      PMCID: PMC3537958          DOI: 10.1016/j.ijscr.2012.09.011

Source DB:  PubMed          Journal:  Int J Surg Case Rep        ISSN: 2210-2612


  9 in total

1.  Long-term results of a prospective randomized trial of adjuvant brachytherapy in soft tissue sarcoma.

Authors:  P W Pisters; L B Harrison; D H Leung; J M Woodruff; E S Casper; M F Brennan
Journal:  J Clin Oncol       Date:  1996-03       Impact factor: 44.544

Review 2.  New frontiers in the treatment of liposarcoma, a therapeutically resistant malignant cohort.

Authors:  Aviad Hoffman; Alexander J Lazar; Raphael E Pollock; Dina Lev
Journal:  Drug Resist Updat       Date:  2010-12-18       Impact factor: 18.500

Review 3.  Clinical and molecular approaches to well differentiated and dedifferentiated liposarcoma.

Authors:  Aimee M Crago; Samuel Singer
Journal:  Curr Opin Oncol       Date:  2011-07       Impact factor: 3.645

4.  Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual data. Sarcoma Meta-analysis Collaboration.

Authors: 
Journal:  Lancet       Date:  1997-12-06       Impact factor: 79.321

5.  Subtype specific prognostic nomogram for patients with primary liposarcoma of the retroperitoneum, extremity, or trunk.

Authors:  Kimberly Moore Dalal; Michael W Kattan; Cristina R Antonescu; Murray F Brennan; Samuel Singer
Journal:  Ann Surg       Date:  2006-09       Impact factor: 12.969

6.  Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity.

Authors:  J C Yang; A E Chang; A R Baker; W F Sindelar; D N Danforth; S L Topalian; T DeLaney; E Glatstein; S M Steinberg; M J Merino; S A Rosenberg
Journal:  J Clin Oncol       Date:  1998-01       Impact factor: 44.544

7.  Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial.

Authors:  Brian O'Sullivan; Aileen M Davis; Robert Turcotte; Robert Bell; Charles Catton; Pierre Chabot; Jay Wunder; Rita Kandel; Karen Goddard; Anna Sadura; Joseph Pater; Benny Zee
Journal:  Lancet       Date:  2002-06-29       Impact factor: 79.321

8.  [Liposarcoma of the ischiorectal fossa, an unusual tumoral site].

Authors:  P Long Pretz; R Detry; P J Kestens; J Haot
Journal:  Acta Chir Belg       Date:  1988 May-Jun       Impact factor: 1.090

9.  Prognostic and predictive factors for outcome to first-line ifosfamide-containing chemotherapy for adult patients with advanced soft tissue sarcomas: an exploratory, retrospective analysis on large series from the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (EORTC-STBSG).

Authors:  Stefan Sleijfer; Monia Ouali; Martine van Glabbeke; Anders Krarup-Hansen; Sjoerd Rodenhuis; Axel Le Cesne; Pancras C W Hogendoorn; Jaap Verweij; Jean-Yves Blay
Journal:  Eur J Cancer       Date:  2010-01       Impact factor: 9.162

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.